What is Shenzhenlubris Pharmaceuticals Co Price-to-Operating-Cash-Flow?
As of today (2024-05-28), Shenzhenlubris Pharmaceuticals Co's share price is ¥26.89.
Shenzhenlubris Pharmaceuticals Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.85. Hence, Shenzhenlubris Pharmaceuticals Co's Price-to-Operating-Cash-Flow Ratio for today is 31.82.
The historical rank and industry rank for Shenzhenlubris Pharmaceuticals Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SZSE:002294'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.39 Med: 25.53 Max: 57.28
Current: 31.77
During the past 13 years, Shenzhenlubris Pharmaceuticals Co's highest Price-to-Operating-Cash-Flow Ratio was 57.28. The lowest was 11.39. And the median was 25.53.
Shenzhenlubris Pharmaceuticals Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥0.21.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.85.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -17.80% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -11.50% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 0.80% per year.
During the past 13 years, Shenzhenlubris Pharmaceuticals Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 106.30% per year. The lowest was -17.80% per year. And the median was 26.60% per year.
Shenzhenlubris Pharmaceuticals Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Shenzhenlubris Pharmaceuticals Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhenlubris Pharmaceuticals Co Price-to-Operating-Cash-Flow Chart
|
Shenzhenlubris Pharmaceuticals Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
13.92 |
20.91 |
24.61 |
37.16 |
43.37 |
|
Shenzhenlubris Pharmaceuticals Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
41.85 |
37.26 |
40.73 |
43.37 |
34.45 |
Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's Price-to-Operating-Cash-Flow
For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhenlubris Pharmaceuticals Co's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's Price-to-Operating-Cash-Flow falls into.
Shenzhenlubris Pharmaceuticals Co Price-to-Operating-Cash-Flow Calculation
Shenzhenlubris Pharmaceuticals Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 26.89 | / | 0.845 |
| = | 31.82 |
Shenzhenlubris Pharmaceuticals Co's Share Price of today is ¥26.89.
Shenzhenlubris Pharmaceuticals Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.85.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description
Traded in Other Exchanges
N/A
Address
1901 Chuangzhan Center, 6007 Shennan Road, Futian District, Shenzhen, CHN
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.
Executives
Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002294 has been successfully added to your